Free Trial

Aridis Pharmaceuticals (ARDS) Short Interest Ratio & Short Volume

Aridis Pharmaceuticals logo
$0.0001 0.00 (-66.67%)
As of 06/4/2025 10:21 AM Eastern

Aridis Pharmaceuticals Short Interest Data

Aridis Pharmaceuticals (ARDS) has a short interest of 1,700 shares. This marks a 0.00% change in short interest from the previous month. The short interest ratio (days to cover) is 0.3, indicating that it would take 0.3 days of the average trading volume of 7,759 shares to cover all short positions.

Current Short Interest
1,700 shares
Previous Short Interest
1,700 shares
Change Vs. Previous Month
No Change
Dollar Volume Sold Short
$0.17
Short Interest Ratio
0.3 Days to Cover
Last Record Date
May 15, 2025
Outstanding Shares
53,321,000 shares
Percentage of Shares Shorted
0.00%
Today's Trading Volume
10,000 shares
Average Trading Volume
7,759 shares
Today's Volume Vs. Average
129%
Short Selling Aridis Pharmaceuticals?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for Aridis Pharmaceuticals and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

ARDS Short Interest Over Time

ARDS Days to Cover Over Time

ARDS Percentage of Float Shorted Over Time

Aridis Pharmaceuticals Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
5/15/20251,700 shares $0.17 No ChangeN/A0.3 $0.00
4/30/20251,700 shares $0.00 No ChangeN/A0.4 $0.00
4/15/20251,700 shares $0.17 No ChangeN/A0.4 $0.00
3/14/20251,700 shares $0.17 No ChangeN/A1.7 $0.00
2/28/20251,700 shares $0.17 No ChangeN/A0.1 $0.00
2/14/20251,700 shares $0.17 No ChangeN/A1.5 $0.00
1/31/20251,700 shares $17.00 No ChangeN/A0.1 $0.01
1/15/20251,700 shares $0.17 No ChangeN/A0.1 $0.00
7/15/20232,430,000 shares $774,927.00 +21.5%N/A0.5 $0.32
6/30/20232,000,000 shares $439,800.00 +8.1%N/A0.6 $0.22
6/15/20231,850,000 shares $499,315.00 +320.7%N/A0.5 $0.27
5/31/2023439,700 shares $174,736.78 -41.9%N/A0.1 $0.40
5/15/2023756,200 shares $161,221.84 +87.0%N/A0.9 $0.21
4/30/2023404,400 shares $72,711.12 -29.5%N/A0.4 $0.18
4/15/2023573,300 shares $126,126.00 +0.3%N/A0.4 $0.22
3/31/2023571,400 shares $179,476.74 -81.3%N/A0.4 $0.31
3/15/20233,060,000 shares $1.27 million +323.8%N/A2 $0.41
2/28/2023722,100 shares $407,264.40 +2.6%N/A0.8 $0.56
2/15/2023703,900 shares $436,418.00 +7.6%N/A0.8 $0.62
1/31/2023654,300 shares $438,381.00 +1,125.3%N/A0.8 $0.67
1/15/202353,400 shares $68,085.00 -44.3%N/A0.2 $1.28
12/30/202295,900 shares $113,162.00 -51.1%N/A0.9 $1.18
12/15/2022196,200 shares $198,162.00 +120.0%N/A1.2 $1.01
11/30/202289,200 shares $81,172.00 -8.0%N/A0.6 $0.91
11/15/202297,000 shares $81,480.00 -7.6%N/A0.7 $0.84
10/31/2022105,000 shares $109,200.00 -49.8%N/A0.7 $1.04
10/15/2022209,000 shares $204,903.60 -55.9%N/A1 $0.98
9/30/2022473,500 shares $440,355.00 +276.7%N/A2.3 $0.93
9/15/2022125,700 shares $227,517.00 +42.2%N/A1.1 $1.81
8/31/202288,400 shares $129,064.00 -53.4%N/A0.7 $1.46
8/15/2022189,700 shares $415,443.00 +53.2%N/A1.5 $2.19
7/31/2022123,800 shares $305,786.00 +28.0%N/A1 $2.47
7/15/202296,700 shares $106,370.00 +3.5%N/A1.8 $1.10
6/30/202293,400 shares $102,740.00 -50.2%N/A1.7 $1.10
6/15/2022187,700 shares $268,411.00 +0.9%N/A2.9 $1.43
5/31/2022186,000 shares $213,900.00 +114.5%N/A2.6 $1.15
5/15/202286,700 shares $80,891.10 -20.8%N/A0.6 $0.93
4/30/2022109,500 shares $136,875.00 +52.1%N/A0.3 $1.25
4/15/202272,000 shares $103,680.00 -36.3%N/A0.1 $1.44
3/31/2022113,000 shares $198,880.00 +32.0%1.2%0.1 $1.76
The Social Security Changes No One’s Talking About (Ad)

While most Americans worry about their next Social Security check... something far bigger is happening behind the scenes. An AI plan — authorized by Executive Order — is about to rewrite how the SSA operates.

To see the full playbook and how it could impact everyone, click here.
3/15/202285,600 shares $130,112.00 -55.0%0.9%0 $1.52
2/28/2022190,000 shares $380,000.00 -77.5%2.0%0.1 $2.00
2/15/2022844,900 shares $2.07 million -67.6%8.9%0.4 $2.45
1/31/20222,610,000 shares $4.72 million +1,272.2%27.6%1.2 $1.81
1/15/2022190,200 shares $292,908.00 +45.9%2.0%0.1 $1.54
12/31/2021130,400 shares $303,832.00 +3,004.8%1.4%0.1 $2.33
12/15/20214,200 shares $9,156.00 -82.1%0.0%0 $2.18
11/30/202123,500 shares $53,110.00 +360.8%0.3%0.7 $2.26
11/15/20215,100 shares $14,229.00 -67.1%0.1%0.2 $2.79
10/29/202115,500 shares $54,250.00 -49.7%0.2%0.4 $3.50
10/15/202130,800 shares $108,416.00 -53.5%0.4%0.5 $3.52
9/30/202166,200 shares $243,616.00 +13.0%0.9%0.4 $3.68
9/15/202158,600 shares $234,400.00 -0.9%0.8%0.4 $4.00
8/31/202159,100 shares $237,582.00 +7.1%0.8%0.4 $4.02
8/13/202155,200 shares $212,520.00 +38.7%0.8%0.3 $3.85
7/30/202139,800 shares $198,602.00 +54.9%0.6%0.3 $4.99
7/15/202125,700 shares $147,004.00 +10.8%0.3%0.2 $5.72
6/30/202123,200 shares $171,680.00 +35.7%0.3%1 $7.40
6/15/202117,100 shares $123,462.00 +11.8%0.2%0.9 $7.22
5/28/202115,300 shares $88,434.00 -32.3%0.2%0.6 $5.78
5/14/202122,600 shares $141,250.00 +43.0%0.3%0.8 $6.25
4/30/202115,800 shares $98,501.94 -8.7%0.2%0.5 $6.23
4/15/202117,300 shares $101,032.00 -22.8%0.2%0.5 $5.84
3/31/202122,400 shares $128,800.00 +63.5%0.3%0.7 $5.75
3/15/202113,700 shares $105,764.00 +61.2%0.2%0.5 $7.72
2/26/20218,500 shares $52,360.00 -30.9%0.1%0.4 $6.16
2/12/202112,300 shares $97,785.00 +66.2%0.2%0.6 $7.95
1/29/20217,400 shares $48,766.00 -9.8%0.1%0.5 $6.59
1/15/20218,200 shares $57,236.00 +64.0%0.1%0.6 $6.98
12/31/20205,000 shares $30,550.00 -12.3%0.1%0.4 $6.11
12/15/20205,700 shares $43,776.00 -31.3%0.1%0.5 $7.68
11/30/20208,300 shares $56,676.55 -27.8%0.1%0.7 $6.83
11/15/202011,500 shares $81,650.00 +38.6%0.2%1 $7.10
10/30/20208,300 shares $53,784.00 -83.2%0.1%0.7 $6.48
10/15/202049,400 shares $366,552.94 -17.3%0.8%4.3 $7.42
9/30/202059,700 shares $422,676.00 +911.9%1.2%5.3 $7.08
9/15/20205,900 shares $42,952.00 -45.4%0.1%0.5 $7.28
8/31/202010,800 shares $75,600.00 -57.7%0.2%1 $7.00
8/14/202025,500 shares $163,455.00 -3.0%0.5%2.5 $6.41
7/31/202026,300 shares $184,100.00 +0.4%0.5%2.6 $7.00
7/15/202026,200 shares $185,496.00 -6.1%0.5%2.5 $7.08
6/30/202027,900 shares $183,861.00 +8.1%0.5%3.5 $6.59
6/15/202025,800 shares $165,120.00 -7.2%0.5%3.5 $6.40

ARDS Short Interest - Frequently Asked Questions

What is Aridis Pharmaceuticals' current short interest?

Short interest is the volume of Aridis Pharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of May 15th, traders have sold 1,700 shares of ARDS short. Learn More on Aridis Pharmaceuticals' current short interest.

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Invesco QQQ ($29.20 billion), Strategy Incorporated ($10.88 billion), iShares 20+ Year Treasury Bond ETF ($10.04 billion), Capital One Financial Co. ($5.51 billion), Charter Communications, Inc. ($5.00 billion), Super Micro Computer, Inc. ($4.43 billion), Apollo Global Management, Inc. ($4.02 billion), Hims & Hers Health, Inc. ($3.65 billion), VanEck Semiconductor ETF ($3.27 billion), and Coinbase Global, Inc. ($3.10 billion). View all of the most shorted stocks.

What does it mean to sell short Aridis Pharmaceuticals stock?

Short selling ARDS is an investing strategy that aims to generate trading profit from Aridis Pharmaceuticals as its price is falling. ARDS shares are trading down $0.00 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Aridis Pharmaceuticals?

A short squeeze for Aridis Pharmaceuticals occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of ARDS, which in turn drives the price of the stock up even further.

How often is Aridis Pharmaceuticals' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ARDS, twice per month. The most recent reporting period available is May, 15 2025.




This page (NASDAQ:ARDS) was last updated on 6/5/2025 by MarketBeat.com Staff
From Our Partners